Sonova Holding (OTCMKTS:SONVY - Get Free Report)'s share price crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $57.63 and traded as low as $56.93. Sonova shares last traded at $57.15, with a volume of 12,511 shares traded.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on the company. BNP Paribas downgraded Sonova from a "strong-buy" rating to a "strong sell" rating in a research note on Wednesday, June 11th. Sanford C. Bernstein raised Sonova from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 18th. HSBC downgraded Sonova from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Kepler Capital Markets raised Sonova from a "strong sell" rating to a "hold" rating in a research note on Friday, June 6th. Finally, Hsbc Global Res downgraded Sonova from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 21st. One research analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Reduce".
Check Out Our Latest Stock Analysis on Sonova
Sonova Stock Up 0.5%
The firm has a 50 day moving average of $57.63 and a two-hundred day moving average of $60.33. The company has a quick ratio of 0.96, a current ratio of 1.27 and a debt-to-equity ratio of 0.45.
Sonova Increases Dividend
The company also recently disclosed a dividend, which was paid on Wednesday, July 2nd. Investors of record on Tuesday, June 17th were paid a $0.6243 dividend. This represents a yield of 99.0%. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from Sonova's previous dividend of $0.57.
Sonova Company Profile
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sonova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sonova wasn't on the list.
While Sonova currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.